Literature DB >> 20937383

Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

Sylvia E Perez1, Bin He, Nadeem Muhammad, Kwang-Jin Oh, Margaret Fahnestock, Milos D Ikonomovic, Elliott J Mufson.   

Abstract

The cholinotrophic system, which is dependent upon nerve growth factor and its receptors for survival, is selectively vulnerable in Alzheimer's disease (AD). But, virtually nothing is known about how this deficit develops in relation to the hallmark lesions of this disease, amyloid plaques and tau containing neurofibrillary tangles. The vast majority of transgenic models of AD used to evaluate the effect of beta amyloid (Aβ) deposition upon the cholinotrophic system over-express the amyloid precursor protein (APP). However, nothing is known about how this system is affected in triple transgenic (3xTg)-AD mice, an AD animal model displaying Aβ plaque- and tangle-like pathology in the cortex and hippocampus, which receive extensive cholinergic innervation. We performed a detailed morphological and biochemical characterization of the cholinotrophic system in young (2-4 months), middle-aged (13-15 months) and old (18-20 months) 3xTg-AD mice. Cholinergic neuritic swellings increased in number and size with age, and were more conspicuous in the hippocampal-subicular complex in aged female than in 3xTg-AD male mice. Stereological analysis revealed a reduction in choline acetyltransferase (ChAT) positive cells in the medial septum/vertical limb of the diagonal band of Broca in aged 3xTg-AD mice. ChAT enzyme activity levels decreased significantly in the hippocampus of middle-aged 3xTg-AD mice compared to age-matched non-transgenic (or wild type) mice. ProNGF protein levels increased in the cortex of aged 3xTg-AD mice, whereas TrkA protein levels were reduced in a gender-dependent manner in aged mutant mice. In contrast, p75(NTR) protein cortical levels were stable but increased in the hippocampus of aged 3xTg-AD mice. These data demonstrate that cholinotrophic alterations in 3xTg-AD mice are age- and gender-dependent and more pronounced in the hippocampus, a structure more severely affected by Aβ plaque pathology. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937383      PMCID: PMC3014453          DOI: 10.1016/j.nbd.2010.10.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  92 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging.

Authors:  Claudio Costantini; Richard Weindruch; Giuliano Della Valle; Luigi Puglielli
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 3.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

4.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 5.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

6.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

7.  Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice.

Authors:  Hans-Joachim Lüth; Jenny Apelt; Amadi O Ihunwo; Thomas Arendt; Reinhard Schliebs
Journal:  Brain Res       Date:  2003-07-04       Impact factor: 3.252

Review 8.  Autophagy, amyloidogenesis and Alzheimer disease.

Authors:  Ralph A Nixon
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

9.  Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations.

Authors:  Julianne A Lombardo; Edward A Stern; Megan E McLellan; Stephen T Kajdasz; Gregory A Hickey; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

10.  The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.

Authors:  L Hu; T P Wong; S L Côté; K F S Bell; A C Cuello
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  32 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

2.  Early Alzheimer's disease-type pathology in the frontal cortex of wild mountain gorillas (Gorilla beringei beringei).

Authors:  Sylvia E Perez; Chet C Sherwood; Michael R Cranfield; Joseph M Erwin; Antoine Mudakikwa; Patrick R Hof; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2015-12-31       Impact factor: 4.673

3.  Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Jessica A Ash; Brian E Powers; Ramon Velazquez; Melissa J Alldred; Milos D Ikonomovic; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

4.  MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.

Authors:  Beatriz E García-Gómez; Francisco J Fernández-Gómez; Encarnación Muñoz-Delgado; Luc Buée; David Blum; Cecilio J Vidal
Journal:  J Mol Neurosci       Date:  2015-12-23       Impact factor: 3.444

5.  Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.

Authors:  Alaina Baker-Nigh; Shahrooz Vahedi; Elena Goetz Davis; Sandra Weintraub; Eileen H Bigio; William L Klein; Changiz Geula
Journal:  Brain       Date:  2015-03-01       Impact factor: 13.501

6.  Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.

Authors:  Tatiana Melnikova; DaMin Park; Lauren Becker; Deidre Lee; Eugenia Cho; Nuzhat Sayyida; Jing Tian; Karen Bandeen-Roche; David R Borchelt; Alena V Savonenko
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

7.  ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice.

Authors:  C Tiveron; L Fasulo; S Capsoni; F Malerba; S Marinelli; F Paoletti; S Piccinin; R Scardigli; G Amato; R Brandi; P Capelli; S D'Aguanno; F Florenzano; F La Regina; A Lecci; A Manca; G Meli; L Pistillo; N Berretta; R Nisticò; F Pavone; A Cattaneo
Journal:  Cell Death Differ       Date:  2013-03-29       Impact factor: 15.828

8.  Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

Authors:  Sylvia E Perez; Muhammad Nadeem; Katherine R Sadleir; Joanna Matras; Christy M Kelley; Scott E Counts; Robert Vassar; Elliott J Mufson
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

9.  Sex steroid levels and AD-like pathology in 3xTgAD mice.

Authors:  Cassia R Overk; Sylvia E Perez; Chunqi Ma; Matthew D Taves; Kiran K Soma; Elliott J Mufson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

10.  Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.

Authors:  Thuy-Vi V Nguyen; Lin Shen; Lilith Vander Griend; Lisa N Quach; Nadia P Belichenko; Nay Saw; Tao Yang; Mehrdad Shamloo; Tony Wyss-Coray; Stephen M Massa; Frank M Longo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.